Skip to main content
OpenTrials
Completed

NCT Number: NCT01312038

Effect of Simethicone on Eustachian Tube Dysfunction

This study is designed to measure the effects of a chewable Simethicone tablet taken by mouth on middle-ear pressure in adults with a common cold and evidence of abnormal middle-ear pressure. In children and adults, middle-ear diseases such as otitis media (the buildup of fluid within the middle ear) and a form of temporary hearing loss occur if the Eustachian tube does not open, does not open often enough or is always open. Simethicone, available over-the-counter under several brand names including Gas-X, may help break up the bubbles that may block the opening of the Eustachian tube in the back of the nose during a cold, allowing air to pass between the nose and middle ear. This study requires a single visit to the Middle Ear Physiology Laboratory in the Oakland section of Pittsburgh. If eligible for the study, Eustachian tube function testing will be done; the Simethicone tablet or placebo (a tablet that looks and tastes like the Simethicone tablet but has no active ingredient) will be given and Eustachian tube function testing repeated.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–50 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 2

Primary location

Middle Ear Physiology Laboratory of Children's Hospital of PIttsburgh of UPMC

Pittsburgh, Pennsylvania, 15213, United States

About this study

For the Eustachian tube function testing, the subject and a technician are seated comfortably within a pressure chamber, a room-like chamber in which the air pressure can be varied much like in an airplane or submarine. Middle ear pressure will be measured in each ear by tympanometry, a test done by inserting a small probe (an earplug attached to a rubber or plastic tube that measures ear pressure) half-way into the ear canal and changing the pressure in the probe. Then, microphones will be placed in the ear canals and a sound source placed into one nostril. The chamber pressure is then decreased and increased to various pressures and middle ear pressure is measured at these various pressures.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age 18 to 50 years
  • Healthy subjects other than current upper respiratory tract infection ("cold")
  • Jackson Score of 6 on screening
  • Subject reports symptom onset within 4 days of entry visit
  • Unilateral or bilateral middle-ear pressure <-50 mmH2O

Exclusion criteria

  • Otoscopic diagnosis of unilateral or bilateral otitis media
  • Presence of tympanostomy tubes or tympanic membrane perforations bilaterally
  • Asthma or any chronic medical disease or condition
  • Use of an "over the counter" medicine within 24 hours of study or prescription within 4 weeks of the study day (except birth control)
  • Use of an experimental drug within 3 months of study
  • An unusual or allergic reaction to simethicone, food dyes, or preservatives
  • Pregnancy or breast feeding
  • Ear surgery other than tympanostomy tube insertion

Treatment and study plan

Simethicone

Drug

single 125 mg chewable tablet

Placebo

Drug

chewable calcium tablet

Primary outcomes

  1. Fraction of Middle Ear (ME) Pressure Equilibrated (FGE)

    Time frame: After achieving the desired ME-pressure chamber gradient at baseline and 30 min post treatment

    The proportion of the pressure chamber-ME pressure gradient equilibrated with 1 swallow

Sponsors and collaborators

Lead sponsor

University of Pittsburgh

Other

Registry information

Official study title

A Pilot Study of the Effect of Simethicone in Adult Subjects With a Common Cold on Eustachian Tube Dysfunction

Important dates

Study start
2011
Primary completion
2014
Study completion
2014
First posted
Mar 10, 2011
Registry last updated
Jun 27, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.